Treatment with the ψεHSP90 peptide enhanced PKCε and HSP90 interactions, enhanced PKCε mitochondrial translocation, increased the phosphorylation and activity of a mitochondrial PKCε substrate, and reduced cardiac injury in animal models of myocardial infarction (Table 3) [120]. This evidence concerns the gene PRKCE and myocardial infarction.